Published 2 days ago • loading... • Updated 5 hours ago
Blood Biomarker Helps Estimate a Person's Future Risk of Cognitive Impairment
The blood test combines p-tau217 with age, sex and APOE ε4 status to estimate risk, with higher levels linked to greater decline.
Summary by News Medical
4 Articles
4 Articles
A Mayo Clinic model uses p-tau217 blood levels, age, sex and genetics to estimate future cognitive impairment risk—but it is not a diagnosis or recommended for routine screening.
A Mayo Clinic study found that p-tau217 blood levels combined with age, sex and genetic risk can estimate five- and 10-year cognitive impairment risk, though the model is not diagnostic.
Blood biomarker helps estimate a person's future risk of cognitive impairment
A blood biomarker for Alzheimer's disease may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia over the next five or 10 years, according to a new Mayo Clinic study in JAMA Neurology.
Mayo Clinic Study Shows Blood Biomarker May Help Estimate Cognitive Impairment Risk
A blood biomarker for Alzheimer's disease may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia over the next five or 10 years, according to a new Mayo Clinic study in JAMA Neurology.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center3Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium





